Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lokesh N Kadabur"'
Autor:
Govind Babu, G.V. Giri, Rajeev Krishnappa Lakkavalli, Jitendra Kumar Pehalajani, Lokesh N Kadabur, Suresh Babu, Venkatesh Tirumala, Linu Abraham Jacob, D Loknatha, Smitha Saldanha, A H Rudresha
Publikováno v:
Journal of cancer research and therapeutics. 17(4)
The treatment landscape of metastatic hormone receptor (HR) positive breast cancer has been changed in recent years. Availability of CDK 4/6 inhibitor and other hormone therapy has changed the treatment algorithm for these patient, we retrospectively
Autor:
Vikas Asati, Deepak Koppaka, Rajesh Patidar, Suresh Babu, L K Rajeev, K Govind Babu, Lokesh N Kadabur, Lokanatha Dasappa, Linu Abraham Jacob, A H Rudresha, C Lakshmaiah Kuntegowdanahalli
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 40:S95-S98
Background: Synovial sarcoma represents 8% of all soft-tissue sarcoma (STS). It is a high-grade STS, and 50% of patients develop metastasis. The most common site of metastasis is the lungs, lymph nodes followed by bones. Ifosfamide-based chemotherapy
Autor:
A Abhishek, Deepak Koppaka, Linu Abraham Jacob, A Usha, Govinda Babu Kanakasetty, Smc Babu, L. Dasappa, Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, L K Rajeev, Rudresha Antapura Haleshappa, Lokesh N Kadabur
Publikováno v:
Indian journal of cancer. 54(1)
Wide use and incorporation of newer diagnostic tools in the management of metastatic nonsmall cell lung cancer (NSCLC) has helped in achieving the goal of personalized treatment of this disease. With the wide use of polymerase chain reaction and fluo
Autor:
Aditi Harsh Thanky, Govind Babu Kanakasetty, Lokesh N Kadabur, Rajeev Krishnappa Lakkavalli, Rudresha Antapura, Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Linu Abraham Jacob, Suresh Babu Mallekavu, Lokanatha Dasappa
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(6)
Many attempts have been made to develop risk prediction scores for chronic myeloid leukemia in chronic phase (CML-CP) to identify the subgroup with a poorer response to therapy to enable early intensification of treatment. Because the bone marrow (BM
Autor:
Rudresha Antapura Haleshappa, Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Linu Abraham Jacob, Rajeev Krishnappa Lakkavalli, Suresh Babu Mallekavu, Lokanatha Dasappa, Govind Babu Kanakasetty, Lokesh N Kadabur, Aditi Harsh Thanky
Publikováno v:
ecancermedicalscience
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder. Over the years many prognostic models have been developed to better risk stratify this disease at baseline. Sokal, Euro, and EUTOS scores were developed in varied populations initially
Autor:
Govind, Kanakasetty Babu, Koppaka, Deepak, Dasappa, Lokanatha, Jacob, Linu Abraham, Babu, Suresh M.C., Lokesh, N. Kadabur, Haleshappa, Rudresha Antapura, Rajeev, L.K., Saldanha, Smitha Carol, Abhishek, Anand, Asati, Vikas, Chethan, R., Ramprasad, Vedam Laxmi
Publikováno v:
South Asian Journal of Cancer; October 2019, Vol. 8 Issue: 4 p247-249, 3p